Oric Pharmaceuticals (ORIC) Free Cash Flow (2019 - 2026)

Oric Pharmaceuticals' Free Cash Flow history runs 8 years deep, the most recent figure standing at -$32.4 million for Q1 2026.

• Quarterly Free Cash Flow rose 1.46% year-over-year to -$32.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$111.2 million (up 4.44% YoY) and the FY2025 annual result came in at -$111.7 million, up 1.9% from the prior year.
• Free Cash Flow was -$32.4 million for Q1 2026 at Oric Pharmaceuticals, down from -$22.7 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$15.6 million in Q4 2022 and bottomed at -$32.9 million in Q1 2025.
• A 5-year average of -$24.8 million and a median of -$24.3 million in 2023 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow plunged 59.36% — and 2025, when it grew 19.68%.
• Oric Pharmaceuticals' Free Cash Flow stood at -$15.6 million in 2022, then slumped by 55.78% to -$24.3 million in 2023, then retreated by 16.22% to -$28.3 million in 2024, then climbed by 19.68% to -$22.7 million in 2025, then sank by 42.84% to -$32.4 million in 2026.
• Business Quant data shows ORIC's Free Cash Flow at -$32.4 million in Q1 2026, -$22.7 million in Q4 2025, and -$25.1 million in Q3 2025.